Quinhydrone is the first
reported cocrystal in 1844
Dr. Childs formed Renovo Research in 2008. Dr. Childs
brings 19 years of experience in crystal engineering to
Renovo and was a pioneer in the field of
pharmaceutical cocrystals. Dr. Childs developed the
screening platform that is used at Renovo to discover
new crystal forms of active pharmaceutical ingredients.
Dr. Childs was instrumental in establishing an initial
business relationship with a private equity backed
venture that resulted in a pipeline of products with new
crystal forms. Dr. Childs has a unique mix of
management, operational, and scientific experience
that complements the mission of Renovo.
The first cocrystal reported was quinhydrone
in 1844 by Friedrich Wöhler (Wöhler, F.
Annalen Chemie Pharmacie 1844, 51,
(b. Eschersheim, near Frankfurt-am-Main,
Germany, 31 July 1800; d Göttingen, Germany,
23 September 1882)
"Wöhler studied quinone and hydroquinone,
established the relationship between them,
and discovered quinhydrone (which he
compared for beauty of color with the
feathers of the hummingbird)." from "Wöhler,
Friedrich." Complete Dictionary of Scientific
2011 Renovo Research, LLC. All rights reserved.
Scott L Childs
cocrystals of pharmaceuticals...
President and Chief Scientific Officer